INVESTMENT AND COMMUNITY SUPPORT FOR VACCINE RESEARCH NEEDED NOW MORE THAN EVER!

INVESTMENT AND COMMUNITY SUPPORT FOR VACCINE RESEARCH NEEDED NOW MORE THAN EVER!

The development of a safe, effective and affordable vaccine is the best tool to end public health diseases that have reached pandemic like HIV and COVID-19. In the past, vaccines have been used to control public health diseases like Polio, Yellow Fever, Measles to mention but a few.  With the global HIV and AIDS pandemic, several vaccine candidates have been tested in clinical trials with progress made though yet to develop an effective vaccine.  An effective HIV vaccine will be beneficial for both HIV negative persons (preventive vaccine) and for the People Living with HIV (Therapeutic vaccine).  HIV vaccine research and development has its own challenges and peculiarities, from understanding the science of the virus and immune correlates to the funding and logistics challenges of holding vaccine clinical trials in a changing HIV prevention landscape. Nevertheless, we must not give up the struggle to develop an effective HIV vaccine that will end the global HIV pandemic.

By Durueke Florita,

Executive Director, NHVMAS.

HIV vaccine will be the most effective means to prevent and eradicate HIV infections

HIV vaccine will be the most effective means to prevent and eradicate HIV infections

Development of a HIV vaccine should be the next action line for scientists to help in reducing the incidence rate especially among people with high risk. The vaccine should help the body’s immune system to recognize and defend against the harmful virus which will control the infection and end HIV globally. We need a powerful array of HIV prevention tools that are widely accessible to all who could benefit from them. HIV vaccine will be the most effective means to prevent and eradicate HIV infections and help save millions of lives.
Funke Awahu – 2020 LeNNiB Champion
WITH INVESTMENT IN HIV VACCINE RESEARCH, THE EPIDEMIC CAN BE STOPPED!

WITH INVESTMENT IN HIV VACCINE RESEARCH, THE EPIDEMIC CAN BE STOPPED!

The human body is designed to fight infections through it’s immune (defense) system which is known as the white blood cells (antibodies) but the antibodies loose their potency after being infected with Human Immunodeficiency Virus.
This leads to the exposure of the human system to wide range of infections which includes tuberculosis and cancer which may result in death if not properly managed through early detection and the use of antiretroviral drugs.
It is estimated that over 60 million men, women and children have been infected since the start of HIV epidemic in the 1980s. In 2019, it was estimated that the epidemic has claimed more than 32 million lives globally (these includes adults, children from low middle income countries which do not have access to antiretroviral drugs). 1.7 million people are newly infected , 14 thousand new infections are recorded daily and 95% of the new infections are in the developing world.
There is hereby, an urgent need to accelerate the development of a cost effective HIV vaccine which will be accessible to all since AIDS (which is the advanced stage of the infection) is the leading cause of death in Africa and the fourth worldwide.

Ayoola Oladosu.
Leaving No One Behind Champion 2020
NHVMAS.

VACCINE: THE PERMANENT REMEDY TO NEW HIV INFECTIONS 

VACCINE: THE PERMANENT REMEDY TO NEW HIV INFECTIONS 

The urgent need for a vaccine to prevent new HIV infections can not be over emphasized in 21st century. An HIV vaccine is a more realistic prospect today than a decade ago.

The UNAIDS estimates that 1.8 million people became infected with HIV in 2017, 36.9 million people were living with HIV and 21.7 million people were receiving antiretroviral therapy.

It is true that researchers have been working on an HIV Vaccine since the 80’s, but progress towards an effective vaccine has been much slower than anticipated.

Hence, there is need for the government of every nation, health NGOs, CSOs (both local and international), along with the World Health Organization (WHO), to partner and form a synergy that would accelerate the research and development of the first and highly effective HIV vaccine that would prevent new HIV infections.

Oghenekome Richard – 2020 LeNNiB Champion. 

An “elixir” that will surely put an end to HIV.

An “elixir” that will surely put an end to HIV.

With over 70 million people worldwide now infected with Human Immunodeficiency Virus (HIV) since the start of the epidemic and recording over 35 million death to Acquired Immune Deficiency Syndrome (AIDS), a preventive vaccine against the virus remains a top priority for human health and our best hope for a world without AIDS.

Truly, there has been a tremendous development in the treatment of HIV infection, but of user fee, side effects from the medication, drug resistance and lack of adherence still remains. With the option of using drug – PrEP – to prevent HIV infection, It’s quite tempting to think that a vaccine may no longer be needed.
The availability of an effective vaccine will help reduce the transmission rate of the virus, eliminate issues around high burden pills and non adherence and would have a big impact on the epidemic and may be enough to significantly reduce new HIV infections among key populations.

It’s no gainsaying that a vaccine would  indeed be an elixir that will eventually put an end to HIV.

Sources

UNAIDS, 2013. Global report: UNAIDS report on the global AIDS epidemic 2013 .

World Health Organization. Global Health Observatory (GHO).

Maria Udoh – 2020 LeNNiB Champion